RR-11a, CAS 1361390-56-8

Product Description: RR-11a is a synthetic enzyme inhibitor of Legumain (IC50=31-55 nM). RR-11a can be used for the research of cancer and acute myocardial infarction (AMI)[1][2][3].

Applications: Cancer-programmed cell death

Formula: C24H28N6O10

References: [1]Liao D, et al. Synthetic enzyme inhibitor: a novel targeting ligand for nanotherapeutic drug delivery inhibiting tumor growth without systemic toxicity. Nanomedicine. 2011 Dec;7(6):665-73./[2]Ralph A, et al. Nanoparticle-based tumor-targeted drug delivery. Patent: CA2809617C/[3]Yang H, et al. Legumain is a predictor of all-cause mortality and potential therapeutic target in acute myocardial infarction. Cell Death Dis. 2020;11(11):1014. Published 2020 Nov 26.

CAS Number: 1361390-56-8

Molecular Weight: 560.51

Compound Purity: 81.51

Research Area: Cancer

Solubility: DMSO : 100 mg/mL (ultrasonic)

Target: Legumain

• SKU: MEXHY-112205-10
• Manufacturer: MedChemExpress
• Manufacturer SKU: HY-112205-10
• Package Unit: 10 mg
• Quantity Unit: STK